These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36475012)

  • 1. Retracted: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2022; 2022():9807439. PubMed ID: 36475012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864232. PubMed ID: 37829402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9780837. PubMed ID: 37829649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
    Zhang C; Cui Y; Wang G; Zhao W; Zhao H; Huang X; Zhang M; Li W
    J Healthc Eng; 2021; 2021():5790416. PubMed ID: 34531966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9823636. PubMed ID: 37885864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9828737. PubMed ID: 37266270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9846548. PubMed ID: 37387965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values.
    Environmental And Public Health JO
    J Environ Public Health; 2023; 2023():9756067. PubMed ID: 38125879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: A Nomogram Predicting the Prognosis of Renal Cell Carcinoma Patients with Lung Metastases.
    International BR
    Biomed Res Int; 2023; 2023():9832720. PubMed ID: 38075299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9838460. PubMed ID: 38550156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862864. PubMed ID: 37476775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retracted] LncRNA GAS6 antisense RNA 1 facilitates the tumorigenesis of clear cell renal cell carcinoma by regulating the AMP‑activated protein kinase/mTOR signaling pathway.
    Guo X; Li H; Zhang M; Li R
    Oncol Lett; 2024 Mar; 27(3):126. PubMed ID: 38333641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the Expression and Clinical Significance of E2F Family in Clear Cell Renal Cell Carcinoma.
    Chen R; Zhang Z; Hu B; Jiang M; Zheng P; Deng W; Fu B; Sun T
    Int J Gen Med; 2022; 15():1193-1212. PubMed ID: 35153510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
    Markers D
    Dis Markers; 2023; 2023():9861260. PubMed ID: 37387768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer.
    Sun CC; Li SJ; Hu W; Zhang J; Zhou Q; Liu C; Li LL; Songyang YY; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; He QQ; Li DJ
    Mol Ther; 2019 Jun; 27(6):1153-1165. PubMed ID: 31010740
    [No Abstract]   [Full Text] [Related]  

  • 17. Retracted: Interfering with the Expression of Ubiquitin-Like with PHD and Ring Finger Domains 1 Can Inhibit the Invasion of Human Renal Cell Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9891043. PubMed ID: 37503429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
    Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
    Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: The Efficacy of Adjuvant Targeted Therapy in Patients with Advanced Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9861537. PubMed ID: 37503398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
    Hu D; Meng N; Lou X; Li Z; Teng Y; Tu B; Zou Y; Wang F
    Int J Gen Med; 2021; 14():3593-3609. PubMed ID: 34295182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.